Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France

por Clay, Emilie, Cristeau, Olivier, Chafaie, Romain, Pinta, Alexandrina, Mazaleyrat, Benjamin, Cottin, Vincent
Publicado 2019

Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in France

por Gaugain, Loïg, Cawston, Hélène, Dubois de Gennes, Coline, Sanchez Alvares, Javier, Nahon, Pierre, Mazaleyrat, Benjamin, Le Dissez, Clément
Publicado 2023